Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse.

The research article investigates how different inhibitors of cyclooxygenase, an enzyme, influence the movement of food through a horse’s small intestine. In particular, the study observes how these inhibitors impact contraction movements in samples of horse ileum (a part of the small intestine) in lab conditions.

Understanding the concept of Cyclooxygenase (COX) inhibitors

• Cyclooxygenase, abbreviated as COX, is an enzyme with two primary types – COX-1 and COX-2. Both are implicated in various functions within the body, including those related to inflammation and pain.
• COX inhibitors are substances that prohibit the action of these enzymes. They are broadly categorized into nonselective inhibitors (inhibit both COX-1 and COX-2) and selective inhibitors (inhibit either COX-1 or COX-2).
• Indomethacin and flunixin meglumine are examples of nonselective COX inhibitors, while SC-560, celecoxib, DUP-398, and NS-697 are examples of selective COX inhibitors.

Procedure of the Research

• Firstly, ileum samples from horses were prepared and tested in isolated organ baths which simulate in-vivo conditions for conducting motility experiments.
• The impact of both nonselective and selective COX inhibitors on these samples were observed, particularly their effects on tonic contraction (continuous contraction) and spontaneous phasic contractions (irregular, spontaneous contractions).
• They investigated the role of prostaglandin (PG), a bioactive substance derived from fatty acids and linked to inflammation and pain, in modulating these effects.
• Some samples were further examined histologically for inflammation and were also tested using reverse transcription-polymerase chain reaction (RT-PCR) to confirm the presence of both COX isoforms mRNA.

Findings of the Study

• Nonselective COX inhibitors did not have any significant impact on ileal motility. The selective COX-1 inhibitor (SC-560) too had no substantial effects on ileal contractions.
• In contrast, the COX-2 selective inhibitors noticeably diminished both tonic and spontaneous phasic contractions.
• However, prostaglandin receptor antagonists (compounds that block PG receptors) were ineffective, indicating that the effects observed due to the COX inhibitors might not be related to the presence or absence of PG.
• The RT-PCR results confirmed inflammation in some ileum samples and the presence of mRNA for both COX-1 and COX-2.

Significance of the Research

• The research provides valuable insights into the potential effects of various COX inhibitors on the small intestinal motility of horses. This could have implications for understanding how these inhibitors might impact digestive health and therapeutic strategies involving COX inhibitors in horses.